Having lupus may increase your risk of food allergies. And certain foods may trigger lupus flares. Learn more.

Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

REPEAT kidney biopsies may play an essential role in managing lupus nephritis, particularly for patients whose disease ...

Panelists discuss the considerations guiding treatment choices for lupus nephritis, such as drug interactions, patient characteristics, and steroid use, and how treatment approaches might differ ...

from systemic lupus erythematosus (SLE) patients and provided protection from clinical disease and tissue pathology in mouse models of lupus, rheumatoid arthritis, and multiple sclerosis.

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with heterogeneous clinical manifestations, often leading to significant morbidity and mortality, particularly due to lupus nephritis ...

1 Jiaxing University Master’s Degree Cultivation Base, Zhejiang Chinese Medical University, Jiaxing, China 2 Department of Rheumatology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, ...

The randomized, double-blind, placebo-controlled, multicenter REGENCY study (ClinicalTrials.gov Identifier: NCT04221477) included patients with International Society of Nephrology/Renal Pathology ...

Sept 30 (Reuters) - Kezar Life Sciences (KZR.O), opens new tab said on Monday it has paused a trial of its experimental drug for lupus to review safety data after four patients died in the mid ...

a kidney disease-related complication of systemic lupus erythematosus. Patients were dosed with either 30 mg of zetomipzomib, 60 mg of zetomipzomib or placebo and standard background therapy.